Cancer cells drive the metabolic heterogeneity of breast cancer, with TNBC exhibiting distinct metabolic phenotypes and more pronounced dysregulation compared to luminal or HER2-enriched subtypes [6]. The gene discussed is ERBB2; the disease is breast carcinoma.